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Abstract 
Previous studies from our laboratory have shown that malondialdehyde-acetaldehyde-protein adducts (MAA adducts) are formed in 
hepatocytes of ethanol-fed rats and directly influence the hepatic stellate cells (HSCs) to induce their secretion of chemokines and to up- 
regulate their expression of adhesion molecules. Since protein kinase C (PKC) is known to play a major role in many diverse intracellular 
signal transduction processes, we investigated whether MAA adducts influence the function of HSCs via a PKC-dependent pathway. 
HSCs in culture were exposed to MAA adducts, and PKC activity was determined. We observed a time- and concentration-dependent 
activation of PKC when cultures were exposed to BSA-MAA as compared with unmodified BSA. Using PKC isoform-specific inhibitors, 
we also showed that BSA-MAA induces the activation of a specific isoform of PKC, PKC-a, in HSCs. No activation of PKC was observed 
when HSCs were exposed to other aldehyde adducts such as BSA-acetaldehyde or BSA-malondialdehyde, indicating that the effects of 
MAA adducts on HSCs were somewhat specific. We further examined whether the observed increase in PKC activation induced by MAA 
adducts in HSCs, in turn, causes a functional effect. We observed that BSA-MAA induces the increased secretion of urokinase-type 
plasminogen activator, a key component of the plasmin-generating system, and that PKC activation is necessary for this enhanced 
urokinase-type plasminogen activator secretion. These results indicate that MAA adducts via a PKC-mediated pathway may regulate 
plasmin-mediated matrix degradation in the liver, thereby contributing to the progression of hepatic fibrosis. 
Krq'word.~: MAA adducts; Urokinase-type plasminogen activator; PKC; Alcoholic liver disease; Hepatic stellate cells 
1. Introduction 
Key players in the pathogenesis of alcohol-induced liver 
injury are the HSCs [I-31. HSCs normally reside in the 
space of Disse in a quiescent, non-proliferative state, in 
close contact with all the major resident liver cells. Follow- 
ing hepatic injury, regardless of etiology, HSCs undergo a 
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Ahbreviution,s: HSCs, hepatic stellate cells; ECM, extracellular matrix; 
MAA adducts, malondialdehyde-acetaldehyde-protein adducts; MDA, 
malondialdehyde; PKC, protein kinase C; PA, plasminogen activator; uPA, 
urokinase-type plasminogen activator; PMA, 4P-phorbol 12P-myristate 
13-acetate; MCP-I , macrophage chemotactic protein-l ; MIP-2, macro- 
phage inflammatory protein-2; ECL, enhanced chemiluminescence. 
complex activation process and become the principal source 
for the increased and irregular deposition of extracellular 
matrix (ECM) components, which characterizes fibrosis 
and cirrhosis [4-71. In addition, HSCs participate in matrix 
remodeling through the synthesis of matrix metalloprotei- 
nases, tissue inhibitors of metalloproteinases, cytokines, and 
components of the plasminogen-activating systems [8-141. 
Many of the toxic effects of ethanol have been linked to 
the formation of adducts, resulting from the covalent 
binding of highly reactive aldehydes such as acetaldehyde, 
malondialdehyde (MDA), and 4-hydroxynonenal, produced 
in the liver during ethanol ingestion, to hepatic proteins, as 
playing a significant role in the development of liver injury 
[15-181. Recent studies from our laboratory have shown 
that acetaldehyde, derived from ethanol metabolism, and 
the lipid peroxidation-derived aldehyde, MDA, can react 
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together with proteins in a synergistic manner to form new 
and distinct hybrid adducts, designated as MAA adducts 
[19]. Definitive chemical characterization of MAA adducts 
has revealed two major structural forms. In addition to the 
highly fluorogenic and immunogenic 2: 1 MAA adduct, in 
which 2 moles of MDA and I mole of acetaldehyde com- 
bine with an amino group of proteins, a 1 : I adduct in which 
1 mole each of MDA and acetaldehyde combine with an 
amino group of a protein has been shown to be the other 
major adduct [20]. Studies from our laboratory have shown 
that MAA adducts are formed in hepatocytes of ethanol- 
fed rats [2 11 and induce the secretion of two chemokines, 
macrophage chemotactic protein- 1 (MCP-I) and macro- 
phage inflammatory protein-2 (MIP-2), as well as increase 
the expression of intercellular adhesion molecule- 1 in HSCs 
in vitro [22]. These results indicated that the MAA adducts 
could directly affect HSCs and contribute to the pathogen- 
esis of alcoholic liver injury. 
PKC is known to play a major role in intracellular signal 
transduction affecting such processes as proliferation, 
differentiation, migration, inflammation, and cytoskeletal 
organization. Investigations over the past decade have 
shown that many effects of ethanol on cell functions are 
closely interconnected with PKC [23]. Since other labora- 
tories have reported the activation of PKC in HSCs con- 
sequent to exposure to aldehydes [24,25], in this study we 
investigated whether the effects of MAA adducts on HSCs 
are transduced via a PKC-dependent pathway. In macro- 
phages, a classical PKC activator, 4P-phorbol 12P-myr- 
istate 13-acetate (PMA), has been shown to up-regulate a 
key component of the plasminogen activating system, 
urokinase-type plasminogen activator (uPA) [26]. Because 
both human and rat HSCs have been shown to produce uPA 
[I 3,141, we also investigated the effect of MAA adducts on 
the secretion of uPA by these cells. We observed that BSA- 
MAA induces the activation of PKC and increases the 
secretion of uPA and that PKC activation is necessary for 
BSA-MAA-induced enhancement of uPA secretion. 
2. Materials and methods 
2.1. Materials 
BSA (Fraction V, fatty acid-free, low endotoxin), col- 
lagenase, Stractan, casein, PMA, and monoclonal anti- 
smooth muscle a-actin were obtained from the Sigma 
Chemical Co. Acetaldehyde was obtained from the Aldrich 
Chemical Co. A chromogenic LAL assay kit was obtained 
from BioWhittaker. Pronase and DNAse were from the 
Boehringer Mannheim Corp. Dulbecco's modified Eagle's1 
F-12 medium (DMEMlF12), glutamine, solutions of anti- 
biotics and an antifungal agent, and trypsin-EDTA were 
from Gibco-BRL. Fetal bovine and horse serum were 
from HyClone Laboratories. The avidin-biotin peroxidase 
kit was from Vector Laboratories. The PKC inhibitors 
Go 6976, rottlerin, myristylated-PKC-[, and calphostin 
C were obtained from the Calbiochem-Novobiochem 
Corp. A Biotrack PKC enzyme assay kit, [ y - " ~ ] ~ ~ ~ ,  
and an enhanced chemiluminescence (ECL) immunode- 
tection kit were obtained from Amersham Pharmacia. 
Plasminogen and D-Val-Leu-Lys-aminomethyl coumarin 
(plasmin substrate) were obtained from Enzyme Systems 
Products. Purified uPA and antibody to uPA were obtained 
from American Diagnostica Inc. Peroxidase-conjugated 
anti-rabbit secondary antibody was from Jackson Immu- 
noresearch Laboratories. Nitrocellulose membrane was 
obtained from Bio-Rad. Protein concentration was mea- 
sured using the BCA protein assay reagent obtained from 
Pierce. All other chemicals used in this study were 
obtained from the Fischer Scientific Co. 
2.2. Generation of BSA-MAA and other adducts 
BSA-MAA was generated by incubating I mg/mL of 
BSA with an equimolar (I mmollL) solution of MDA and 
acetaldehyde for 3 days at 37" in a sealed polypropylene 
vessel in a non-oxidizing atmosphere as detailed in our 
earlier publication [19]. Unmodified BSA was used as a 
control. Additional controls such as acetaldehyde- or MDA- 
adducts of these proteins were made utilizing similar 
conditions for incubation and with the same molar con- 
centration of acetaldehyde or MDA alone as used in the 
generation of MAA adducts. Since HSCs are responsive 
to LPS and results in activation of PKC,~ we took utmost 
care to generate the various adducts under pyrogen-free 
conditions. The endotoxin levels in our adducted and non- 
adducted samples, monitored using the chromogenic LAL 
assay, were always below the detectable range of <0.06 
endotoxin units/mL. 
2.3. Isolation and culture o f  HSCs 
Male Wistar rats (Charles River Laboratories) were 
maintained at the Omaha VA Medical Center animal 
facility accredited by the American Association for the 
Accreditation of Laboratory Animal Care (AAALAC). All 
animals received humane care in accordance with the 
guidelines of the National Institute on Drug Abuse, 
National Institute of Health, and the Guide for the Care 
and Use of Laboratory Animals (Institute of Laboratory 
Animal Resources, Commission on Life Sciences, 
National Research Council, 1996). 
The HSCs were isolated from 3-month-old rats using 
sequential pronase and collagenase perfusion followed by 
density gradient centrifugation with Stractan [27]. The 
viability of the cells was evaluated by trypan blue exclu- 
sion, and HSCs were identified by their typical phase 
contrast light microscopic appearance and by the presence 
of fat droplets detected by ultraviolet light. The purified 
' Kharbanda KK and Tuma DJ, unpublished observations 
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HSCs were cultured on uncoated plastic (75-cm2 flask) at 
37" in a humidified atmosphere containing 5% C02  as 
described by Friedman and Roll [27] in 1:l DMEMlF12 
supplemented with 10% fetal bovine serum, 10% horse 
serum, 2 mmol/L of glutamine and 1% solutions of anti- 
biotics and an antifungal agent. The medium was replaced 
24 hr after seeding the cells and every 48 hr thereafter. At 
confluence, the cells were detached with a trypsin-EDTA 
solution and split 1:4 each time for subculture. A repre- 
sentative from each subculture was stained by the avidin- 
biotin peroxidase technique following the instructions of 
the manufacturer (Vector Laboratories) using monoclonal 
anti-smooth muscle a-actin. Under these culture condi- 
tions, HSCs proliferated and became fully activated within 
8-10 days of primary culture. 
The experiments described in this study were done on 5- 
9 independent cell lines and were performed between 
passages 1 and 6. The HSCs in passages 1-6, all of which 
were smooth muscle a-actin positive (indicating that all 
these cells were activated), were trypsinized, and 2.5 x 10" 
cells were plated in uncoated 60-mm petri dishes in serum 
containing medium for PKC-related studies. When the 
plates were 60% confluent, the cells were washed with 
medium without serum and exposed to unmodified BSA or 
BSA-MAA in serum-free medium for up to 72 hr. At the 
end of the exposure time, tissue culture medium was 
discarded, 250 yL of cold lysis buffer (50 mmol/L Tris- 
HCl, pH 7.4, containing leupeptin, phenylmethylsulfonyl 
fluoride, and aprotinin) was added immediately, and the 
dishes were flash-frozen for PKC assay. To establish the 
specificity of BSA-MAA, HSCs were also exposed to 
BSA-acetaldehyde or BSA-MDA adducts, and the activity 
of PKC was determined. 
2.5. Effect of BSA-MAA on uPA secretion by HSCs 
The secretion of uPA was quantitated by chromogenic 
substrate assay, casein zymography, and Western blotting 
techniques. For these studies, cells grown in uncoated 
24-well plates in serum-containing medium were washed 
twice with serum-free medium and incubated with BSA- 
MAA or unmodified BSA in 1 mL of serum-free DMEMI 
F12 for 24 hr. After incubation, the media were collected, 
centrifuged at 10,000 g for 7 min at 4", and the super- 
natants were stored at -70" until assay. The cells were 
lysed in 250 yL of 0.1 % SDS to determine total DNA [29]. 
2.6. Determination of uPA activity by chromogenic 
substrate assay 
Quantification of uPA activity in the conditioned med- 
ium was performed utilizing a functional assay for plasmin 
[26]. Briefly, purified uPA or aliquots (300 pL) of serum- 
free supernatants of conditioned medium were added to 
tubes with buffer (PBS, pH 7.6, with 0.05% Tween-20). 
Then 5 pg of plasminogen and 13 pg of the plasmin sub- 
strate D-Val-Leu-Lys-aminomethyl coumarin were added 
to all tubes. Each conditioned medium sample had its own 
blank in which no plasminogen was added. This was done 
to eliminate interference in the assay by plasmin or other 
non-specific proteases in the sample. Samples were mixed 
and incubated in a 37" water bath. The concentration of 
aminomethyl coumarin produced was measured fluorome- 
trically at excitation and emission wavelengths of 370 and 
460 nm, respectively. Activity of plasminogen activator 
(PA) in the conditioned medium was extrapolated from a 
standard curve utilizing purified uPA, and the data were 
expressed as mIU/yg of DNA. 
2.4. Assay of PKC activity 
2.7. Casein zymography 
The cells were scraped from dishes and sonicated. The 
cell lysate was centrifuged at 10,000 g for 30 min at 4" to 
separate the cytosolic and particulate fractions. The parti- 
culate fraction was extracted with lysis buffer containing 
Triton X- 100. PKC activity was determined in both frac- 
tions by a procedure employed previously [28] using the 
substrate peptide (VRKRTLRRL) in 20 yL of kit mix and 
20 pL of M~-[~- '~P]ATP in a Tris-HC1 buffer (pH 7.5). 
Samples (20 pL) were added to 40 yL of the above reaction 
mixture and incubated for 15 min at 30". Incubations were 
stopped by spotting 50 pL of each sample onto P-81 
phosphocellulose paper (Whatman). The papers were 
washed five times for 5 min each in 75 mmol/L of phos- 
phoric acid and one time in ethanol and then air-dried and 
counted in non-aqueous scintillant. Kinase activity was 
calculated in relation to total cellular protein assayed and 
was expressed in pmol/(min mg). No less than three 
independent tests on different cellular preparations were 
performed per parameter. Data were analyzed for statistical 
significance using Student's t-test. 
For the detection of PA by zymography, samples of 
conditioned media were separated on 10% SDS-polyacry- 
lamide gels containing 2 mg/mL of casein and 0.25 mg/mL 
of plasminogen under non-reducing conditions according 
to the zymography procedure of Waghray and Webber 
[30]. The volume of the conditioned medium loaded per 
lane was such that it corresponded to an equal cell number 
or DNA amount. After electrophoresis, the gels were 
incubated for 30 min in a 2.5% solution of Triton X-100 
and then incubated overnight at 37" in 50 mmol/L of Tris, 
100 mmol/L of NaCl, pH 7.6. The gels were stained with a 
0.5% solution of Coomassie blue and destained in 30% 
methanol and 10% acetic acid. The uPA activity (case- 
inolytic activity) was identified as clear bands on a uniform 
blue background following destaining. The gels were 
dried, and densitometric analyses were performed using 
the Molecular Dynamics personal SI and ImageQuant 
software. To rule out the possibility that the activity being 
determined by casein zymography was not due to plasmin, 
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conditioned media were also separated in casein-SDS- 
polyacrylamide gels in the absence of plasminogen. 
2.8. Western blotting 
Samples of conditioned media (corresponding to an 
equal cell number or DNA amount) in electrophoresis 
loading buffer [SOmmollL of Tris-HC1 (pH 6.8), 2% 
SDS, 2% P-mercaptoethanol, 10% glycerol, and 0.001% 
bromophenol blue] were separated on a 10% SDS-poly- 
acrylamide gel. Protein transfer was performed onto a 
nitrocellulose filter using a transblot apparatus containing 
25 mmol/L of Tris-HC1 (pH 8.3), 192 mmol1L of glycine, 
and 20% methanol. The blots were blocked for 1 hr at 37" 
with Blotto (PBS, pH 7.4,0.05% Tween-20,5% nonfat dry 
milk) and then were incubated overnight in Blotto contain- 
ing 1: 1000 diluted polyclonal antibody against uPA. After 
extensive washing in PBS-Tween-20, the blots were incu- 
bated for 1 hr at 25" in Blotto containing 0.5 pg1mL of 
peroxidase-conjugated anti-rabbit secondary antibody. 
Blots were washed extensively with PBS-Tween-20, 
washed once with PBS, developed using ECL, and exposed 
to film. Densitometric analyses were performed using 
the Molecular Dynamics personal SI and ImageQuant 
software. 
2.9. Statistical analysis 
Statistical analysis was performed by the paired Stu- 
dent's t-test. A probability value of <0.05 was considered 
significant. 
3. Results 
To examine whether BSA-MAA activates PKC in 
HSCs, we initially exposed HSCs to 50 pglmL of BSA- 
MAA or unmodified BSA for up to 72 hr. We observed a 
time-dependent activation of PKC activity in HSCs treated 
with 50 pg1mL of BSA-MAA (Fig. 1). BSA-MAA maxi- 
mally activated PKC (2.0-fold increase, P < 0.05) at 2 hr 
after exposure compared to the medium control and 
decreased to unstimulated levels by 24 hr and remained 
so at 48 and 72 hr (Fig. 1). In contrast to BSA-MAA, there 
was no effect of unmodified BSA on PKC activation at any 
of the time points tested. To determine the concentration- 
dependent effect of BSA-MAA on HSCs, the cells were 
treated with 0-100 pg1mL of BSA-MAA for 2 hr. We 
observed a concentration-dependent activation of PKC 
up to 62.5 pglmL, beyond which a decrease in PKC 
activity was observed (Fig. 2). To establish the specificity 
of the BSA-MAA response, we also examined other 
aldehyde adducts. At a concentration similar to that of 
BSA-MAA, which induced activation of PKC, no effect of 
50 pglmL of BSA-acetaldehyde or BSA-MDA adduct 
was observed at either 2 or 24 hr of treatment (Table I). 
Rat HSCs have been shown to express at least four 
different PKC isoforms: PKC-a, -6, -8, and -c [31]. To 
further delineate which isoform of PKC is activated by 
BSA-MAA, we used isoform-specific inhibitors I hr 
before exposing the cells for 2 hr to 50 pg1mL of BSA- 
MAA. The various inhibitors used were 100 nmollL of Go 
6976 (PKC-a specific inhibitor), 2 pmollL of rottlerin 
(PKC-6 specific inhibitor), 40 nmollL of myristylated- 
0.25 2 24 48 72 
Time (hr) 
Fig. I.  Time course of BSA-MAA-induced PKC activation. PKC activity was determined in HSCs exposed to medium alone (a), 50 pg/mL of unmodified 
BSA (O) ,  or 50 pg/mL of BSA-MAA (V) for up to 72 hr. PMA (v) at a concentration of 100 ng/mL was used as a positive control. Results are presented as 
means + SEM of four determinations. An asterisk (*) indicates that the value is significantly different (P < 0.05) from the medium-alone control. 
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BSA-MAA (yglmL) 
Fig. 2. Concentration-dependent effect of BSA-MAA on PKC activation. HSCs were exposed to different concentrations of BSA-MAA (0-100 pg/mL) for 
2 hr, and PKC activity was determined. Results are presented as means f SEM of four determinations. HSCs were incubated with serum-free medium alone 
for 2 hr as a control. An asterisk (*) indicates that the value is significantly different (P < 0.05) from the control. 
PKC-I (PKC-I specific inhibitor), or 1 pmol/L of calphos- 
tin C (isoform-indiscriminate general PKC inhibitor). Of 
all the inhibitors tested, only Go 6976, the PKC-c~ specific 
inhibitor, and calphostin C, an isoform-indiscriminate 
inhibitor, were able to inhibit the BSA-MAA-induced 
increase in PKC translocation, whereas rottlerin or myr- 
istylated-PKC-[ had no effect (Fig. 3), indicating that the 
effects of MAA are mediated via the PKC-a isoform and 
not the PKC-S or the -[ isoform. 
We next examined whether BSA-MAA-induced PKC 
activation could, in turn, modulate PA secretion by HSCs. 
HSCs were exposed to 50 pg/mL of BSA-MAA or the 
unmodified BSA for 24 hr, and the PA activity in the 
conditioned medium was quantified by a chromogenic 
substrate assay. We detected an -2-fold increase in PA 
secretion by HSCs exposed to BSA-MAA as compared 
with the BSA-treated control (Fig. 4). It should be pointed 
out that when employing the chromogenic substrate assay, 
the only PA activity that we could demonstrate was with 
Table 1 
using the conditioned medium. Leyland et al. [13], using 
acid glycine to dissociate protein-receptor interactions, 
had shown cell-surface associated PA in HSCs. However, 
we could not detect any cell receptor-associated PA activity 
when the cell surface was stripped with acid glycine. 
The PA activity in the conditioned medium of the HSCs 
was also determined by casein-plasminogen-SDS-PAGE 
zymography. The underlying principle behind this techni- 
que is that following electrophoresis and renaturation, PA 
converts plasminogen, which is incorporated in the poly- 
acrylamide gel, to plasmin which degrades the casein that 
is also incorporated into the gel. The degraded area appears 
unstained following staining with Coomassie blue. Not 
only is this technique widely used to semi-quantify PA 
activity, but it also gives an accurate determination of 
the molecular mass of the plasminogen activator. When 
conditioned media from HSCs were analyzed by the casein 
zymography technique, a prominent lytic band correspond- 
ing to a molecular mass of -33 kDa was observed (Fig. 5) .  
Densitometric analysis revealed a 2.2-fold increase in 
uPA secretion by HSCs treated with BSA-MAA as com- 
Effect of other aldehyde BSA-adducta on PKC activation pared to those treated with BSA. NO lytic bands were 
PKC activity (pmol/(min mg) protein) observed when the conditioned medium from cells exposed 
to either unmodified BSA or BSA-MAA-treated samples 
2 hr 24 hr 
were analyzed by zymography in SDS-polyacrylamide 
Unmodified BSA (control) 129.3 f 30.4 93.6 * 42.3 gels containing only casein (data not shown). This indi- 
BSA-acetaldehyde 142.3 f 20.8" 147.6 & 5.2" cated that plasmin was not being secreted by HSCs under 
B SA-MDA 103.6 f 25.6" 144.6 + 14.5" basal or BSA-MAA-induced conditions. The conditioned 
HSCS were exposed to 50 pg/mL of unmodified BSA, BSA- medium obtained from these cells was also analyzed by a 
acetaldehyde or BSA-MDA adducts for 2 and 24 hr, and the activity of 
PKC was determined as detailed in Section 2. Results are means & SEM Western blotting technique using an antibody to uPA. 
( N  = 4). Results showed a single sharp band representing the 
"Not significantly different from its corresponding control. 33 kDa uPA in medium from BSA-MAA or unmodified 
.- + + BSA-MAA I 
Fig. 3. Effect of PKC isoforn-specific inhibitors on BSA-MAA-stimulated PKC activation. HSCs were exposed to isoforn-specific inhibitors 1 hr before the 
addition of 50 pg/mL of BSA-MAA for 2 hr. The various inhibitors used were 100 nmollL of Gii 6976 (PKC-a specific inhibitor), 2 pmol/L of rottlerin 
(PKC-S specific inhibitor), 40 nmolL of myristylated-PKC-l; (PKC-1; specific inhibitor), or 1 pmolL of calphostin C (isoform-indiscriminate PKC inhibitor). 
HSCs were incubated with serum-free medium alone for 2 hr to serve as a control. Results are presented as means f SEM of four determinations. An asterisk 
(*) indicates that the value is significantly different (P < 0.05) from the control. No significant difference was observed when the samples treated with BSA- 
MAA alone were compared with samples treated with myristylated-PKC-i; + BSA-MAA or rottlerin + BSA-MAA. 
u 
J 
a 0 
Unmodified BSA BSA-MAA 
Fig. 4. Effect of BSA-MAA on PA activity in the conditioned medium. 
HSCs were exposed to 50 pg/mL of unmodified BSA or BSA-MAA for 
24 hr, and the PA activity was determined in the conditioned medium using 
the chromogenic substrate assay as detailed in Section 2. Results are 
presented as means & SEM (N = 4 different cellular preparations). An 
asterisk (*) indicates that the value is significantly different (P < 0.0008) 
from its corresponding control. 
Unmodified 
BS A BSA-MAA 
Fig. 5. SDS-PAGE zymograms showing the effect of BSA-MAA on the 
secretion of uPA. The conditioned medium of HSCs exposed to 50 pg/mL 
of unmodified BSA or BSA-MAA for 24 hr was analyzed by SDS-PAGE 
zymography using plasminogen and casein as substrates as described in 
Section 2. Each column represents the mean + SEM (N = 9 different 
cellular preparations) of the volume integration units. An asterisk (*) 
indicates P < 0.0006. The zymogram shown above the columns is from 
one representative experiment. Lanes 1 and 2, BSA; lanes 3 and 4, BSA- 
MAA. The lytic bands correspond to a molecular mass of 33 kDa. 
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Fig. 6. Western blot analysis showing the effect of BSA-MAA on the 
secretion of uPA. Conditioned medium of HSCs exposed to 50 pg/mL of 
unmodified BSA or BSA-MAA for 24 hr was separated on 10% PAGE, 
and proteins were transblotted onto nitrocellulose and stained with 
antibody to uPA as detailed in Section 2. Blots are from two separate 
experiments. The bands correspond to a molecular mass of 33 kDa. Lanes 
1 and 3, BSA; lanes 2 and 4, BSA-MAA. The densitometric analyses, 
represented as mean volume integration units, are BSA, 51.9; BSA-MAA, 
83.7. 
BSA-treated HSCs (Fig. 6). This was similar to what was 
observed on the casein zymograms. Additionally, the 
Western blots corroborated our results obtained by both 
the chromogenic substrate assay and casein zymography, 
verifying that BSA-MAA induces increased secretion of 
33 kDa uPA. It is noteworthy that the 33 kDa moiety 
corresponds to the active low molecular mass uPA, which 
has been shown to be devoid of binding sites for the uPA 
receptor on the cell surface. This could explain why we did 
not detect any cell-bound uPA in our chromogenic sub- 
strate assay. 
To determine whether this BSA-MAA-induced increase 
in uPA was mediated via a PKC-dependent pathway, 
calphostin C, a PKC inhibitor, was added to the cells 
1 hr before the addition of unmodified BSA or BSA- 
a 1400 
k 5 1200 
5 loo0 
I- 
800 
@ 600 
t 
k' 400 3 200 
g 0 
Calphostin C 
BSA 
BSA-MAA 
Fig. 7. Effect of calphostin C, a PKC inhibitor, on BSA-MAA-induced uPA 
activity in the conditioned medium analyzed by SDS-PAGE zymograms. 
HSCs were preincubated with or without 1 prnolk of calphostin C for 1 hr 
in serum-free medium. Then unmodified BSA or BSA-MAA (50 pg/mL 
each) was added, and cells were incubated for another 24 hr. Conditioned 
medium was recovered and assayed for PA activity by SDS-PAGE zymo- 
graphy using plasminogen and casein as substrates as described in Section 
2. Each column represents the mean of the volume integration units f SEM 
(N = 5 different cellular preparations). An asterisk (*) indicates a value 
significantly different (P < 0.01) from the control. The zymogram shown 
above the columns is from one representative experiment. Lane 1, BSA, 
lane 2, calphostin C + BSA; lane 3, BSA-MAA; and lane 4, calphostin 
C + BSA-MAA. 
MAA for 24 hr. We observed that calphostin C was able 
to abrogate significantly the BSA-MAA-induced uPA 
secretion by 90%, but had no effect on the constitutive 
secretion of uPA (Fig. 7). 
4. Discussion 
In this study, we investigated the role of the PKC path- 
way in the transductional effects of MAA adducts on HSCs 
and their downstream effects. Our present study provides 
evidence that BSA-MAA utilizes the activation of a 
specific isoform of PKC, PKC-a, as a possible pathway 
of signaling events in HSCs. Furthermore, our results 
indicate that PKC activation is necessary for BSA- 
MAA-induced uPA secretion. 
In experiments reported here, BSA-MAA induced a 
time-dependent activation of PKC in HSCs. Peak stimula- 
tion of PKC was observed 2 hr after exposure to BSA- 
MAA. In contrast to BSA-MAA, unmodified BSA did not 
stimulate PKC activity at any of the time points tested. The 
specificity of BSA-MAA on PKC activation in HSCs was 
also established by evaluating the effects of other aldehyde 
adducts. When examined at a concentration similar to that 
of BSA-MAA, which induced activation of PKC, no effect 
of BSA-acetaldehyde or BSA-MDA adduct was observed 
at either 2 or 24 hr of treatment. In addition to the time- 
dependent activation of PKC by BSA-MAA, we also 
observed a concentration-dependent stimulation of PKC 
activity in HSCs treated with 0-62.5 pg/mL of BSA-MAA 
for 2 hr. Although we observed a stimulation of PKC 
activity at 75 and 100 yg/mL of BSA-MAA as compared 
with the control, the stimulation in kinase activity was less 
than that observed at 50 and 62.5 pg/mL of BSA-MAA. 
We believe that we did not observe a concentration-depen- 
dent stimulation in PKC activity when HSCs were exposed 
to >62.5 pg/mL of BSA-MAA for 2 hr because of the 
possible down-regulation or auto-inhibition of PKC activ- 
ity at 2 hr when exposed to concentrations of BSA-MAA 
greater than 62.5 yg/mL. Such concentration- and time- 
dependent down-regulation of PKC has been documented 
in cells exposed to PMA, a known activator of PKC [32-341. 
Since rat HSCs have been shown to express at least four 
different PKC isoforms, PKC-a, -6, -E, and -[ [31], we also 
examined which PKC isoforms were activated by using 
isoform-specific inhibitors before exposing the cells to 
BSA-MAA. Of all the inhibitors tested, only Go 6976 
and calphostin C were able to inhibit the increase in PKC 
translocation, indicating that the effects of BSA-MAA in 
HSCs are likely mediated via the PKC-a isoform. 
We previously reported that BSA-MAA causes 
increased secretion of MCP-1 and MIP-2 by HSCs [22]. 
However, our observations that PKC inhibitors were 
unable to abrogate or mitigate the MAA-induced chemo- 
kine secretion (see footnote 1) implied that BSA-MAA 
does not utilize the PKC-mediated pathway to increase 
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MCP-1 or MIP-2. We then explored other possible func- 
tional downstream effects of PKC activation in HSCs. The 
observations that PMA, a classical PKC activator, stimu- 
lates uPA expression in macrophages [26] and that rat 
HSCs produce uPA [I31 led us to investigate whether 
BSA-MAA-induced PKC stimulation could, in turn, mod- 
ulate PA secretion by HSCs. When HSCs were exposed to 
BSA-MAA, there was an increase of uPA secretion in the 
treated cells compared with the control cells, as quantified 
by the chromogenic substrate assay. These results on the 
BSA-MAA-induced increase in uPA were also corrobo- 
rated by casein zymography. The advantage of using the 
casein zymography technique rather than the chromogenic 
substrate assay to semi-quantify the PA activity is that the 
molecular mass of the active moiety can be determined. 
Additionally, since HSCs have also been shown to secrete 
plasminogen activator inhibitor [35] and while the casein 
zymography technique will separate the inhibitor from the 
PA during electrophoresis, there is a probability of the 
inhibitor interfering in the chromogenic substrate assay, 
which could result in an underestimation of the PA activity. 
Because of the advantages listed above, we performed 
casein zymography and observed a significant increase 
in MAA-induced uPA secretion. To rule out the possibility 
that BSA-MAA is inducing the secretion of plasmin by the 
HSCs, the conditioned media were also separated on 10% 
SDS-polyacrylamide gels containing only 2 mg/mL of 
casein and no plasminogen. The lack of any lytic bands 
in these gels confirmed that the HSCs are induced to 
secrete uPA, and not plasmin, after exposure to BSA- 
MAA. Both Western blot analysis and casein zymography 
revealed that BSA-MAA increases secretion of 33 kDa 
low molecular mass uPA. It was particularly intriguing that 
BSA-MAA induced an -2-fold activation in PKC as well 
as an -2-fold increase in secretion of uPA by HSCs. 
Furthermore, we observed that calphostin C was able to 
not only abrogate MAA-induced PKC activation, but also 
MAA-induced uPA secretion. The uPA activity measure- 
ments were obtained at 24 hr, well after the PKC activity 
has returned to unstimulated levels. This is a classical 
example of the signal transduction pathways where a 
cascade of events that are temporally and spatially linked 
takes place. Taken together, our results imply that the effect 
of BSA-MAA on promoting uPA secretion is mediated via 
a PKC-dependent pathway. 
We have demonstrated for the first time that exposure of 
HSCs to MAA adducts can stimulate PKC activation, 
which leads to increased uPA secretion. We do not know 
at present whether the increased uPA secretion induced by 
BSA-MAA is a result of increased uPA gene expression or 
post-transcriptional modulation. The mechanism by which 
MAA adducts activate PKC is also presently unknown. 
However, we believe that the interaction of MAA adducts 
with surface receptors on HSCs results in the activation of 
PKC and generation of its downstream effects. In this 
regard, a family of receptors, classified as scavenger 
receptors [36], which are known to bind and endocytose 
a wide variety of aldehyde-adducted proteins, is a possible 
candidate for binding MAA adducts and initiating signal- 
ing events that lead to increased uPA secretion. Our 
hypothesis is supported by the report that binding of 
fucoidan or acetylated low-density lipoprotein to scaven- 
ger receptors on a macrophage cell line induces uPA 
expression via a PKC-mediated signaling pathway [37]. 
Current studies are in progress to investigate this mechan- 
ism. 
In the studies reported here, we provide evidence that 
MAA adducts increase secretion of uPA by HSCs via a 
PKC-dependent pathway. The implications of our results 
are potentially important. The serine protease uPA cleaves 
its specific and intrinsic substrate, plasrninogen, to gen- 
erate plasmin. The broad-spectrum proteinase, plasmin, 
degrades fibrin and other components of the ECM [38], 
thereby playing an important role in physiological and 
pathological pathways involving cell migration and tissue 
remodeling. In addition, plasmin also regulates the activity 
of some members of the metalloproteinases that require 
activation, e.g. interstitial collagenase and stromelysin 
[39]. Through proteolysis, uPA also activates pre-interleu- 
kin 8, hepatocyte growth factor, and vascular endothelial 
growth factor, and, via generation of plasmin, it activates 
transforming growth factor-p [4042]. Thus, the plasmin- 
generating system associated with HSCs plays a central 
role in the control of HSC biology by both regulating 
pericellular matrix degradation and activating fibrogenic 
growth factors. Beyond its role as a facilitator of extra- 
cellular proteolysis and an activator of growth factors, uPA 
has been reported to induce proliferation of HSCs [14]. 
Thus, BSA-MAA, by inducing increased uPA secretion by 
HSCs, could play a profound role in the perpetuation of 
alcoholic liver disease through matrix remodeling, genera- 
tion of the most potent profibrogenic factor, transforming 
growth factor-P, and increased proliferation. Secretion of 
uPA has been shown to be increased by agents such as 
platelet-derived growth factor, basic-fibroblast growth fac- 
tor, acetaldehyde, and retinoic acid, all of which have been 
shown to play an important role in the pathogenesis of 
alcoholic liver disease [13,14,43]. Thus, BSA-MAA can 
be added to the list of factors that may play an important 
role in the initiation and pathogenesis of alcoholic liver 
disease. 
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